Concepedia

Annsofi Nihlén

AN

Statistics

Publications

12

Citations

484

H-Index

12

Active since

1995

Affiliations

Science for Life Laboratory(Current)

Uppsala University Hospital

Karolinska Institutet

Annsofi Nihlén is an author at Science for Life Laboratory specializing in toxicology, pharmacy, and toxicokinetics.

Publications per year

1995–2012

12

Publications

12

A phase 1 trial of recombinant human IL-21 in combination with cetuximab in patients with metastatic colorectal cancer

Nicola Steele, A Anthony, Mark Saunders et al. · British Journal of Cancer · 2012 · 88 citations · Full text

, , +17

Experimental Exposure to Methyltertiary-Butyl Ether

Annsofi Nihlén, Robert Wålinder, Agneta Löf et al. · Toxicology and Applied Pharmacology · 1998 · 77 citations

, , +7

Toxicokinetics and acute effects of MTBE and ETBE in male volunteers

Gunnar Johanson, Annsofi Nihlén, Agneta Löf · Toxicology Letters · 1995 · 71 citations

, , +7

Experimental Exposure to Methyltertiary-Butyl Ether

Annsofi Nihlén, Agneta Löf, Gunnar Johanson · Toxicology and Applied Pharmacology · 1998 · 57 citations

, , +7

Controlled Ethyltert-Butyl Ether (ETBE) Exposure of Male Volunteers*1II. Acute Effects

Annsofi Nihlén · Toxicological Sciences · 1998 · 36 citations

, , +17

1–5 of 12